Literature DB >> 78729

Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism.

E Regoeczi, M T Debanne, M C Hatton, A Koj.   

Abstract

The capacity of the liver to eliminate asialofetuin and asialoorosomucoid was investigated in intact rats. From plasma radioactivity curve measurements and assays on tissue homogenates the liver is shown to be able to dispose of an average of 19.8 microgram of asialofetuin/min per 100 g body weight. No other major route is identified for the disappearance of asialofetuin from the plasma, although trace amounts of the protein were detectable in the urine. From analyses of the plasma radioactivity curves the elimination process for asialoorosomucoid appears to be comparatively complex because of the existence of extrahepatic disposal routes. Quantification of labelled asialoorosomucoid in liver homogenates indicates, however, that the hepatic clearance rate for asialoorosomucoid is similar to that for asialofetuin. Urinary excretion significantly contributes to the disappearance of asialoorosomucoid from the plasma but the hepatic and renal routes do not account for all the protein lost from this compartment. At plasma concentrations above the maximal eliminative capacity of the liver, the hepatic clearance of asialofetuin obeys zero-order kinetics and is remarkably constant. Elimination of a quantity of asialoglycoprotein which exceeds the calculated total number of binding sites in the liver does not reduce the efficiency of the pathway, and studies of [3H]leucine incorporation indicate that the lectin, unlike the bound asialoglycoprotein, is not destroyed in the elimination process. Cytochalasin B (80 microgram/100 g body wt.) had no measureable effect on the hepatic clearance of asialofetuin. Administration of colchicine (10 mg/100 g body wt.) resulted in transitory accumulations of asialoorosomucoid in the liver, presumably due to interference with the intracellular transport of the endocytised protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78729     DOI: 10.1016/0304-4165(78)90196-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  In vivo quantification of removal of asialo-orosomucoid from the circulation in anaesthetized streptozotocin-diabetic rats.

Authors:  M Appel; P Potrat; J Feger; C Mas-Chamberlin; G Durand
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

2.  Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.

Authors:  D B Cawley; D L Simpson; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Identification, purification, and partial characterization of an organic anion binding protein from rat liver cell plasma membrane.

Authors:  A W Wolkoff; C T Chung
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

4.  Selective hepatic uptake of human beta-hexosaminidase A by a specific glycoprotein recognition system on sinusoidal cells.

Authors:  C J Steer; J W Kusiak; R O Brady; E A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.

Authors:  H Ishihara; T Hara; Y Aramaki; S Tsuchiya; K Hosoi
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

6.  Relationship between pinocytic rate and uptake of transferrin by suspended rat hepatocytes.

Authors:  J R Rudolph; E Regoeczi
Journal:  Biol Met       Date:  1991

7.  Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.

Authors:  T Hasegawa; I Makino
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

8.  In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall.

Authors:  Teresa R McCurdy; Varsha Bhakta; Louise J Eltringham-Smith; Sharon Gataiance; Alison E Fox-Robichaud; William P Sheffield
Journal:  J Biomed Biotechnol       Date:  2012-04-01

9.  Receptor-mediated endocytosis of asialoglycoproteins by rat hepatocytes: receptor-positive and receptor-negative endosomes.

Authors:  S C Mueller; A L Hubbard
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

10.  Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors.

Authors:  Tan-Min Chin; Gandhi T K Boopathy; Ellen P S Man; John G Clohessy; Eva Csizmadia; Margaret P Quinlan; Thomas Putti; Seow-Ching Wan; Chen Xie; Azhar Ali; Fhu Chee Wai; Yan Shan Ong; Boon-Cher Goh; Jeff Settleman; Wanjin Hong; Elena Levantini; Daniel G Tenen
Journal:  Theranostics       Date:  2020-02-03       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.